NCT01992952 2025-11-26
FAKTION
Velindre NHS Trust
Phase 1/2 Active not recruiting
Clinical Trials
16 trialsNCT06522971 2025-09-10
CancerBeat
Latvian Biomedical Research and Study Centre
Phase NA Active not recruiting
NCT03578484 2025-07-04
Breast Aesthetics by Three Dimensional Measures
Sykehuset Telemark
Active not recruiting
NCT03963427 2025-07-03
GoBreast
Vastra Gotaland Region
Phase NA Active not recruiting
NCT04461808 2025-06-25
MAITA
Azienda USL Reggio Emilia - IRCCS
Phase NA Active not recruiting
NCT04862429 2025-06-25
BoCCE
Azienda USL Reggio Emilia - IRCCS
Phase NA Active not recruiting
NCT06394661 2025-06-23
Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer
Henan Cancer Hospital
Phase 2 Active not recruiting
NCT05969314 2025-04-11
To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer
Tata Memorial Hospital
Phase 1 Active not recruiting
NCT01916317 2025-04-09
Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer
Tata Memorial Hospital
Phase 3 Active not recruiting
NCT02161900 2025-04-09
Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer
Tata Memorial Hospital
Phase NA Active not recruiting
NCT03168880 2025-04-09
TNBC
Tata Memorial Hospital
Phase 3 Active not recruiting
NCT05682885 2025-01-22
ELYBS
Dharmais National Cancer Center Hospital
Phase NA Active not recruiting
NCT03408717 2024-10-09
B-CAPP
KK Women's and Children's Hospital
Active not recruiting
NCT06531447 2024-08-01
First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients
The National Center of Oncology, Azerbaijan
Phase 2 Active not recruiting
NCT03423199 2024-03-22
PATHWAY
National Cancer Center, Japan
Phase 3 Active not recruiting
NCT03756298 2023-11-09
Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Center, Korea
Phase 2 Active not recruiting